ArticleJournal of diabetes and metabolic disorders2026

Cardiovascular outcomes with tirzepatide versus semaglutide in type 2 diabetes.

Mohammed Al-Nusair et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.